Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6713247

Title:Human CNS cell lines and methods of use therefor
Inventors:Sah, Dinah W. Y.; San Diego, CA, USA
Gage, Fred H.; La Jolla, CA, USA
Ray, Jasodhara; San Diego, CA, USA
Summary:Described herein are methods of producing conditionally-immortalised human central nervous system progenitor cells, which may be clonal or for use in generating neurons or astrocytes. Therapeutic applications of such cell lines and differentiated cells are provided, such as in the development of agents useful in the prevention and treatment of CNS-related diseases and in assays for the study of CNS cell development and abnormalities.
Abstract:Conditionally-immortalized human CNS progenitor cell lines are provided. Such cell lines, which may be clonal, may be used to generate neurons and/or astrocytes. Such cell lines and/or differentiated cells may be used for the development of therapeutic agents to prevent and treat a variety of CNS-related diseases. Such cell lines and/or differentiated cells may also be used in assays and for the general study of CNS cell development, death and abnormalities.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6713247
Application Number:US1996000711628
Date Filed:03/09/1996
Date Published:30/03/2004
Assignee:Signal Pharmaceuticials, Inc., San Diego, CA, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/13/2021